FGF23 and Klotho in Relation to Markers of Endothelial Dysfunction in Kidney Transplant Recipients.

Background Fibroblast growth factor (FGF) 23 is a newly discovered member of the FGF family. Klotho is a cofactor of FGF23. Activation of the FGF23-Klotho system is responsible for negative phosphate balance. In addition, FGF23 appears to be a risk factor for cardiovascular complications. The aim of this study was to assess levels of FGF23 and Klotho in stable kidney transplant recipients on triple immunosuppressive therapy in relation to comorbidities and markers endothelial dysfunction. Healthy volunteers served as a control group. Methods Hemoglobin, urea, and creatinine were studied with the use of standard laboratory methods in the hospital central laboratory. We assessed FGF23 and Klotho, markers of endothelial function/injury von Willebrand factor (vWF), intercellular adhesion molecule (ICAM), vascular cell adhesion molecule (VCAM), and interleukin (IL) 6, N-terminal pro–B-type natriuretic peptide (NT-proBNP) and copeptin with the use of commercially available assays. Results FGF23 was significantly higher and Klotho significantly lower in kidney transplant recipients compared with healthy volunteers. FGF23 correlated with copeptin ( r = 0.28; P < .05), IL-6 ( r = 0.39; P < .01), VCAM ( r = 0.36; P < .01), time after transplantation ( r = 0.31; P < .05), platelet count ( r = 0.31; P < .05), mean corpuscular volume ( r = −0.40; P < .01), and phosphate ( r = 0.31; P < .05). Klotho correlated with NT-proBNP ( r = 0.38; P < .01), vWF ( r = −0.26; P < .05), calcium ( r = −0.39; P < .01), and age ( r = 0.45; P < .001). FGF23 was significantly higher and Klotho significantly lower in patients with estimated glomerular filtration rate (eGFR) >60 mL/min compared with patients with eGFR <60 mL/min. Conclusions Disturbances in the FGF23-Klotho system appeared to be related to the endothelial cell injury. Thus they are involved not only in pathogenesis of the metabolic bone disease but also in cardiovascular complications, particularly in kidney disease. [ABSTRACT FROM AUTHOR]